Compounds > vecuronium bromide

Page last updated: 2024-08-23

vecuronium bromide and Muscle Weakness

vecuronium bromide has been researched along with Muscle Weakness in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (37.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jankowski, S; Jones, C; Mulleague, L	1
Kimura, T; Nakajima, M; Nishikawa, T; Sato, K	1
Alkhazrajy, W; Khorasanee, AD; Russell, WJ	1
Akai, H; Horikawa, Y; Iijima, K; Ijichi, K; Takekida, S; Tanaka, O; Tanaka, Y; Wake, M	1
David, WS; Davies, SF; Fluegel, WL; Iber, C; Leatherman, JW	1
Coakley, J	1
Aziz, L; Choudhury, SN; Hirakawa, M; Jahangir, SM; Ohta, Y; Rahman, K	1
Borsa, S; Pignataro, A; Pozzato, M; Quarello, F; Rollino, C; Vallero, A; Visetti, E	1

Reviews

1 review(s) available for vecuronium bromide and Muscle Weakness

Article	Year
Should ICU patients receive muscle relaxants? Schweizerische medizinische Wochenschrift, 1996, Sep-28, Volume: 126, Issue:39 Topics: Atracurium; Critical Care; Humans; Intensive Care Units; Muscle Weakness; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide	1996

Other Studies

7 other study(ies) available for vecuronium bromide and Muscle Weakness

Article	Year
The use of neuromuscular blockers to facilitate mechanical ventilation in severe asthma. British journal of hospital medicine (London, England : 2005), 2009, Volume: 70, Issue:1 Topics: Adult; Asthma; Humans; Male; Muscle Weakness; Neuromuscular Blocking Agents; Respiration, Artificial; Severity of Illness Index; Vecuronium Bromide	2009
Vecuronium was safely used in a patient with Engelmann's disease without muscle weakness. Journal of anesthesia, 2012, Volume: 26, Issue:3 Topics: Adult; Camurati-Engelmann Syndrome; Female; Humans; Muscle Weakness; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide	2012
Muscle weakness after muscle relaxants: an audit of clinical practice. Anaesthesia and intensive care, 2004, Volume: 32, Issue:2 Topics: Age Factors; Androstanols; Anesthesia, General; Cholinesterase Inhibitors; Female; Hand Strength; Humans; Male; Medical Audit; Muscle Weakness; Neostigmine; Neuromuscular Nondepolarizing Agents; Postoperative Period; Risk; Rocuronium; Sex Factors; Time Factors; Vecuronium Bromide	2004
[Prolonged paralysis after long-term administration of vecuronium in the intensive care unit]. Masui. The Japanese journal of anesthesiology, 2006, Volume: 55, Issue:8 Topics: Female; Humans; Intensive Care Units; Middle Aged; Muscle Weakness; Neuromuscular Nondepolarizing Agents; Paralysis; Renal Insufficiency; Respiration, Artificial; Vecuronium Bromide	2006
Muscle weakness in mechanically ventilated patients with severe asthma. American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Albuterol; Asthma; Atracurium; Bronchodilator Agents; Cohort Studies; Female; Glucocorticoids; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Muscle Weakness; Muscular Diseases; Neuromuscular Nondepolarizing Agents; Pancuronium; Respiration, Artificial; Retrospective Studies; Risk Factors; Time Factors; Vecuronium Bromide	1996
The effect of priming with vecuronium and rocuronium on young and elderly patients. Anesthesia and analgesia, 1997, Volume: 85, Issue:3 Topics: Adult; Aged; Androstanols; Anesthesia; Female; Humans; Intubation, Intratracheal; Male; Muscle Weakness; Neuromuscular Nondepolarizing Agents; Oxygen; Respiratory Mechanics; Rocuronium; Vecuronium Bromide	1997
Is vecuronium toxicity abolished by hemodialysis? A case report. Artificial organs, 2000, Volume: 24, Issue:5 Topics: Cholinesterase Inhibitors; Female; Graft Rejection; Humans; Kidney Transplantation; Middle Aged; Muscle Weakness; Neostigmine; Neuromuscular Nondepolarizing Agents; Renal Dialysis; Respiration, Artificial; Respiratory Paralysis; Vecuronium Bromide	2000